References

• Arendowski, A., Szulc, J., Nizioł, J., Gutarowska, B., & Ruman, T. (2018). Metabolic profiling of moulds with laser desorption/ionization mass spectrometry on gold nanoparticle enhanced target. Analytical Biochemistry, 549(1), 45–52. https://doi.org/10.1016/j.ab.2018.03.016
   PubMed Web of Science ®Google Scholar
• Bakhrushina, E. O., Anurova, M. N., Demina, N. B., & Ivannikov, G. Y. (2019). Main aspects of pharmaceutical gel development for peroral administration. Drug Synthesis Methods and Manufacturing Technology, 53(9), 838–844. https://doi.org/10.1007/s11094-019-02087-9
   Google Scholar
• Chen, L., Liu, Y., Guo, Q., Zheng, Q., & Zhang, W. (2018). Metabolomic comparison between wild Ophiocordyceps sinensis and artificial cultured Cordyceps militaris. Biomedical Chromatography, 11(9), e4279. https://doi.org/10.1002/bmc.4279
   Google Scholar
• Denning, D. W. (2003). Echinocandin antifungal drugs. The Lancet, 362(9390), 1142–1151. https://doi.org/10.1016/S0140-6736(03)14472-8
   PubMed Web of Science ®Google Scholar
• Doi, T., Muraoka, T., Ohshiro, T., Matsuda, D., Yoshida, M., Takahashi, T., Omura, S., & Tomoda, H. (2012). Conformationally restricted analog and biotin-labeled probe based on beauveriolide III. Bioorganic & Medicinal Chemistry Letters, 22(1), 696–699. https://doi.org/10.1016/j.bmcl.2011.10.045
   PubMed Web of Science ®Google Scholar
• Elsworth, J. F., & Grove, J. F. (1977). Cyclodepsipeptides from Beauveria bassiana Bals. Part 1. Beauverolides H and I. Journal of the Chemical Society, Perkin Transactions, 1(3), 270–273. https://doi.org/10.1039/p19770000270
   Google Scholar
• Hutter-Paier, B., Huttunen, H. J., Puglielli, L., Eckman, C. B., Kim, D. Y., Hofmeister, A., Moir, R. D., Domnitz, S. B., Frosch, M. P., Windisch, M., & Kovacs, D. M. (2004). The ACAT inhibitor CP-113,818 markedly reduces amyloid pathology in a mouse model of Alzheimer’s disease. Neuron, 44(2), 227–238. https://doi.org/10.1016/j.neuron.2004.08.043
   PubMed Web of Science ®Google Scholar
• Isogai, A., Kanaoka, M., Matsuda, H., Hori, Y., & Suzuki, A. (1978). Structure of a new cyclodepsipeptide beauverilide A from Beauveria bassiana. Agricultural and Biological Chemistry, 42(9), 1797–1798. https://doi.org/10.1080/00021369.1978.10863252
   Web of Science ®Google Scholar
• Jegorov, A., Kadlec, Z., Novák, J., Maťha, V., Sedmera, P., Tříska, J., & Zahradníčkova, H. (1990). Are the depsipeptides of Beauveria brongniartii involved in the entomopathogenic process? In A. Jegorov & V. Maťha (Eds.), Biopesticides, theory and practice (pp. 71–82). House of Technics CSVTS.
   Google Scholar
• Jegorov, A., Paizs, B., Kuzma, M., Zabka, M., Landa, Z., Sulc, M., Barrow, M. P., & Havlicek, V. (2004). Extraribosomal cyclic tetradepsipeptides beauverolides: Profiling and modeling the fragmentation pathways. Journal of Mass Spectrometry, 39(8), 949–960. https://doi.org/10.1002/jms.674
   PubMed Web of Science ®Google Scholar
• Kadlec, Z., Šimek, P., Heydová, A., Jegorov, A., Maťha, V., Landa, Z., & Eyal, J. (1994). Chemotaxonomic discrimination among the fungal genera Tolypocladium, Beauveria and Paecilomyces. Biochemical Systematics and Ecology, 22(8), 803–806. https://doi.org/10.1016/0305-1978(94)90083-3
   Web of Science ®Google Scholar
• Kapojos, M. M., Abdjul, D. B., Yamazaki, H., Ohshiro, T., Rotinsulu, H., Wewengkang, D. S., Sumilat, D. A., Tomoda, H., Namikoshi, M., & Uchida, R. (2018). Callyspongiamides A and B, sterol O-acyltransferase inhibitors, from the Indonesian marine sponge Callyspongia sp. Bioorganic & Medicinal Chemistry Letters, 28(10), 1911–1914. https://doi.org/10.1016/j.bmcl.2018.03.077
   PubMed Web of Science ®Google Scholar
• Karlsson, M., Pukenas, B., Chawla, S., Ehinger, J. K., Plyler, R., Stolow, M., Gabello, M., Hugerth, M., Elmér, E., Hansson, M. J., Margulies, S., & Kilbaugh, T. (2019). Neuroprotective effects of cyclosporine in a porcine pre-clinical trial of focal traumatic brain injury. Journal of Neurotrauma, 36(1), 14–24. https://doi.org/10.1089/neu.2018.5706
   Web of Science ®Google Scholar
• Kunjathoor, V. V., Wilson, D. L., & LeBoeuf, R. C. (1996). Increased atherosclerosis in streptozotocin-induced diabetic mice. Journal of Clinical Investigation, 97(7), 1767–1773. https://doi.org/10.1172/JCI118604
   PubMed Web of Science ®Google Scholar
• Madariaga-Mazon, A., Gonzalez-Andradeb, M., Toriello, C., Navarro-Barranco, H., & Mata, R. (2015). Potent anti-calmodulin activity of cyclotetradepsipeptides isolated from Isaria fumosorosea using a newly designed biosensor. Natural Product Communications, 10(1), 113–116. https://doi.org/10.1177/1934578X1501000128
   PubMed Web of Science ®Google Scholar
• Marzetta, C. A., Savoy, Y. E., Freeman, A. M., Long, C. A., Pettini, J. L., Hagar, R. E., Inskeep, P. B., Davis, K., Stucchi, A. F., Nicolosi, R. J., & Hamanaka, E. S. (1994). Pharmacological properties of a novel ACAT inhibitor (CP-113,818) in cholesterol-fed rats, hamsters, rabbits, and monkeys. Journal of Lipid Research, 35(10), 1829–1838. https://www.jlr.org/content/35/10/1829.long
   PubMed Web of Science ®Google Scholar
• Matsuda, D., Namatame, I., Tomoda, H., Kobayashi, S., Zocher, R., Kleinkauf, H., & Omura, S. (2004). Bew beauveriolides produced by amino acid-supplemented fermentation of Beauveria sp. FO-6979. The Journal of Antibiotics, 57(1), 1–9. https://doi.org/10.7164/antibiotics.57.1
   PubMed Web of Science ®Google Scholar
• Nagai, K., Doi, T., Ohshiro, T., Sunazuka, T., Tomoda, H., Takahashi, T., & Omura, S. (2008). Synthesis and biological evaluation of a focused library of beauveriolides. Bioorganic & Medicinal Chemistry Letters, 18(15), 4397–4400. https://doi.org/10.1016/j.bmcl.2008.06.054
   PubMed Web of Science ®Google Scholar
• Nagai, K., Doi, T., Sekiguchi, T., Namatame, I., Sunazuka, T., Tomoda, H., Omura, S., & Takahashi, T. (2006). Synthesis and biological evaluation of a beauveriolide analogue library. Journal of Combinatorial Chemistry, 8(1), 103–109. https://doi.org/10.1021/cc050084d
   PubMedGoogle Scholar
• Nakaya, S., Mizuno, S., Ishigami, H., Yamakawa, Y., Kawagishi, H., & Ushimaru, T. (2012). New rapid screening method for anti-aging compounds using budding yeast and identification of beauveriolide I as a potent active compound. Bioscience, Biotechnology, and Biochemistry, 76(6), 1226–1228. https://doi.org/10.1271/bbb.110872
   PubMed Web of Science ®Google Scholar
• Namatame, I., Tomoda, H., Ishibashi, S., & Omura, S. (2004). Antiatherogenic activity of fungal beauveriolides, inhibitors of lipid droplet accumulation in macrophages. Proceedings of the National Academy of Sciences of the USA, 101(3), 737–742. https://doi.org/10.1073/pnas.0307757100
   PubMed Web of Science ®Google Scholar
• Namatame, I., Tomoda, H., Si, S., Yamaguchi, Y., Masuma, R., & Omura, S. (1999b). Beauveriolides, specific inhibitors of lipid droplet formation in mouse macrophages, produced by Beauveria sp. FO-6979. The Journal of Antibiotics, 52(1), 1–6. https://doi.org/10.7164/antibiotics.52.1
   PubMed Web of Science ®Google Scholar
• Namatame, I., Tomoda, H., Tabata, N., Si, S., & Omura, S. (1999a). Structure elucidation of fungal beauveriolide III, a novel inhibitor of lipid droplet formation in mouse macrophages. The Journal of Antibiotics, 52(1), 7–12. https://doi.org/10.7164/antibiotics.52.7
   PubMed Web of Science ®Google Scholar
• Nielsen, D. S., Shepherd, N. E., Xu, W., Lucke, A. J., Stoermer, M. J., & Fairlie, D. P. (2017). Orally absorbed cyclic peptides. Chemical Reviews, 117(12), 8094–8128. https://doi.org/10.1021/acs.chemrev.6b00838
   PubMed Web of Science ®Google Scholar
• Ohshiro, T., Imuta, S., Hijikuro, I., Yagyu, H., Takahashi, T., Doi, T., Ishibashi, S., & Tomoda, H. (2020). The Anti-atherOgenic activity of beauveriolide derivative BVD327, a SterOl O-acyltransferase 2-Selective InhibitOr, in ApOlipOprOtein E KnOckOut mice. Biological & Pharmaceutical Bulletin, 43(6), 951–958. https://doi.org/10.1248/bpb.b19-00913
   PubMed Web of Science ®Google Scholar
• Ohshiro, T., Kobayashi, K., Ohba, M., Matsuda, D., Rudel, L. L., Takahashi, T., Doi, T., & Tomoda, H. (2017). Selective inhibition of sterol O-acyltransferase 1 isozyme by beauveriolide III in intact cells. Scientific Reports, 7(1), 4163. https://doi.org/10.1038/s41598-017-04177-8
   PubMedGoogle Scholar
• Ohshiro, T., Matsuda, D., Nagai, K., Doi, T., Sunazuka, T., Takahashi, T., Rudel, L. L., Omura, S., & Tomoda, H. (2009). The selectivity of beauveriolide derivatives in inhibit ion toward the two isozymes of acyl-CoA: Cholesterol acyltransferase. Chemical & Pharmaceutical Bulletin, 57(4), 377–381. https://doi.org/10.1248/cpb.57.377
   PubMed Web of Science ®Google Scholar
• Ohshiro, T., Namatame, I., Nagai, K., Sekiguhi, T., Doi, T., Takahashi, T., Akasaka, K., Rudel, L. L., Tomoda, H., & Omura, S. (2006). Absolute stereochemistry of fungal beauveriolide III and ACAT inhibitory activity of four stereoisomers. The Journal of Organic Chemistry, 71(20), 7643–7649. https://doi.org/10.1021/jo0611667
   PubMed Web of Science ®Google Scholar
• Ohshiro, T., Rudel, L. L., Omura, S., & Tomoda, H. (2007). Selectivity of microbial Acyl-CoA: Cholesterol acyltransferase inhibitors toward isozymes. The Journal of Antibiotics, 60(1), 43–51. https://doi.org/10.1038/ja.2007.6
   PubMed Web of Science ®Google Scholar
• Park, Y. J., Lee, S. R., Kim, D. M., Yu, J. S., Beemelmanns, C., Chung, K. H., & Kim, K. H. (2018). The inhibitory effects of cyclodepsipeptides from the entomopathogenic fungus Beauveria bassiana on myofibroblast differentiation in A549 alveolar epithelial cells. Molecules, 23(10), E2568. https://doi.org/10.3390/molecules23102568
   PubMed Web of Science ®Google Scholar
• Puglielli, L., Konopka, G., Pack-Chung, E., Ingano, L. A., Berezovska, O., Hyman, B. T., Chang, T. Y., Tanzi, R. E., & Kovacs, D. M. (2001). Acyl-coenzyme A: Cholesterol acyltransferase modulates the generation of the amyloid β-peptide. Nature Cell Biology, 3(10), 905–912. https://doi.org/10.1038/ncb1001-905
   PubMed Web of Science ®Google Scholar
• Reintjes, T. (Ed). (2011). Solubility enhancement with BASF Pharma polymers. Solubilizer compendium. BASF SE.
   Google Scholar
• Šimčíková, D., Tůma, P., Jegorov, A., Jr., Šimek, P., & Heneberg, P. (2020). Rapid methods for the separation of natural mixtures of beauverolides, cholesterol acyltransferase inhibitors, isolated from the fungus Isaria fumosorosea. Journal of Separation Science, 43(5), 962–969. https://doi.org/10.1002/jssc.201901084
   PubMed Web of Science ®Google Scholar
• Smith, S. G. (1996). Neoral®(cyclosporin) in dermatology: Technical aspects. British Journal of Dermatology, 135(48), 2–4. https://doi.org/10.1111/j.1365-2133.1996.tb00701.x
   PubMed Web of Science ®Google Scholar
• Tomoda, H., & Doi, T. (2008). Discovery and combinatorial synthesis of fungal metabolites beauveriolides, novel antiatherosclerotic agents. Accounts of Chemical Research, 41(1), 32–39. https://doi.org/10.1021/ar700117b
   PubMed Web of Science ®Google Scholar
• Tuan, N. N., Ngan, N. T., Kuo, P. C., Hung, H. Y., Lan, T. N., Thang, N. T., Xuan, D. T. T., Thang, T. D., & Wu, T. S. (2017). Characterization of cyclodepsipeptides from the mycelium of Isaria japonica from Vietnam. Natural Product Communications, 12(3), 377–378. https://doi.org/10.1177/1934578X1701200317
   PubMed Web of Science ®Google Scholar
• Ueda, H., Ikeda, H., Sasaki, Y., & Shioji, R. (1978). Effect of oral administration of calcium carbonate, aluminium hydroxide gel and dihydrotachysterol on renal acidosis. Tohoku Journal of Experimental Medicine, 124(1), 1–11. https://doi.org/10.1620/tjem.124.1
   PubMed Web of Science ®Google Scholar
• Vilcinskas, A., Jegorov, A., Landa, Z., Götz, P., & Maťha, V. (1999). Effects of beauverolide L and cyclosporine A on humoral and cellular immune response of the greater wax moth, Galleria mellonella. Comparative Biochemistry and Physiology. Part C, Pharmacology, Toxicology & Endocrinology, 122(1), 83–92. https://doi.org/10.1016/S0742-8413(98)10082-8
   PubMed Web of Science ®Google Scholar
• Wang, C. K., & Craik, D. J. (2016). Cyclic peptide oral bioavailability: Lessons from the past. Biopolymers, 106(6), 901–909. https://doi.org/10.1002/bip.22878
   PubMed Web of Science ®Google Scholar
• Wang, C. K., Northfield, S. E., Swedberg, J. E., Colless, B., Chaousis, S., Price, D. A., Liras, S., & Craik, D. J. (2015). Exploring experimental and computational markers of cyclic peptides: Charting islands of permeability. European Journal of Medicinal Chemistry, 97(1), 202–213. https://doi.org/10.1016/j.ejmech.2015.04.049
   PubMed Web of Science ®Google Scholar
• Wang, X., Gao, Y.-L., Zhang, M.-L., Zhang, H.-D., Huang, J.-Z., & Li, L. (2020). Genome mining and biosynthesis of the Acyl-CoA: Cholesterolacyltransferase inhibitor beauveriolide I and III in Cordyceps militaris. Journal of Biotechnology, 309(1), 85–91. https://doi.org/10.1016/j.jbiotec.2020.01.002
   PubMed Web of Science ®Google Scholar
• Witter, D. P., Chen, Y., Rogel, J. K., Boldt, G. E., & Wentworth, P., Jr. (2009). The natural products beauveriolide I and III: A new class of β-amyloid-lowering compounds. ChemBioChem, 10(8), 1344–1347. https://doi.org/10.1002/cbic.200900139
   PubMed Web of Science ®Google Scholar